Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | KDM6B | O15054 | 1/20 | 0.45 |
| ▸ | KDM5C | P41229 | 1/20 | 0.45 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.45 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.45 |
| ▸ | DGKA | P23743 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.41 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | PAM | P19021 | 2/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3802391 | 0.98 | ALDH1A1 (0.48) | ALDH1A1ADRA2AADRA1AEGLN1MAPT | |
| Ammonia Solution, Strong SCHEMBL27753018 | 0.98 | ALDH1A1 (0.48) | ALDH1A1ADRA2AADRA1AEGLN1MAPT | |
| SCHEMBL2880910 | 0.94 | ALDH1A1 (0.45) | ALDH1A1ADRA2AADRA1AEGLN1MAPT | |
| SCHEMBL17796306 | 0.94 | ALDH1A1 (0.45) | ALDH1A1ADRA2AADRA1AEGLN1MAPT | |
| SCHEMBL25585247 | 0.94 | ALDH1A1 (0.45) | ALDH1A1ADRA2AADRA1AEGLN1MAPT | |
| SCHEMBL28946417 | 0.94 | ALDH1A1 (0.45) | ALDH1A1ADRA2AADRA1AEGLN1MAPT | |
| SCHEMBL818345 | 0.94 | ALDH1A1 (0.45) | ALDH1A1ADRA2AADRA1AEGLN1MAPT | |
| SCHEMBL1264931 | 0.94 | ALDH1A1 (0.45) | ALDH1A1ADRA2AADRA1AEGLN1MAPT | |
| SCHEMBL17796302 | 0.94 | ALDH1A1 (0.45) | ALDH1A1ADRA2AADRA1AEGLN1MAPT | |
| SCHEMBL28323524 | 0.94 | ALDH1A1 (0.45) | ALDH1A1ADRA2AADRA1AEGLN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220274966-A1 | SURFACTANT SYSTEMS FOR CRYSTALLIZATION OF ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2022-09-01 | — | — | US | claimed |
| EP-3436450-B9 | REACTION MEDIUM CONTAINING WATER-SURFACTANT MIXTURE | NOVARTIS AG (CH) | 2022-07-06 | — | — | EP | claimed |
| EP-3436450-B1 | REACTION MEDIUM CONTAINING WATER-SURFACTANT MIXTURE | NOVARTIS AG (CH) | 2022-03-09 | — | — | EP | claimed |
| US-11236076-B2 | Reaction medium containing water-surfactant mixture | NOVARTIS AG (CH) | 2022-02-01 | — | — | US | claimed |
| US-11220681-B2 | Enzymatic reaction medium containing surfactant | NOVARTIS AG (CH) | 2022-01-11 | — | — | US | claimed |
| US-20200299281-A1 | REACTION MEDIUM CONTAINING WATER-SURFACTANT MIXTURE | TECHNICAL R&D, SUZHOU NOVARTIS PHARMA TECH CO LTD. (CN) | 2020-09-24 | — | — | US | claimed |
| US-20190308180-A1 | CATALYSTS FOR CHEMICAL REACTIONS IN A WATER-SURFACTANT MIXTURE | SUZHOU NOVARTIS PHARMA TECHNOLOGY CO., LTD (CN) | 2019-10-10 | — | — | US | claimed |
| EP-3519400-A1 | SURFACTANT SYSTEMS FOR CRYSTALLIZATION OF ORGANIC COMPOUNDS | Novartis AG (CH) | 2019-08-07 | — | — | EP | claimed |
| EP-3484618-A1 | CATALYSTS FOR CHEMICAL REACTIONS IN A WATER-SURFACTANT MIXTURE | NOVARTIS AG (CH) | 2019-05-22 | — | — | EP | claimed |
| EP-3436450-A1 | REACTION MEDIUM CONTAINING WATER-SURFACTANT MIXTURE | Novartis AG (CH) | 2019-02-06 | — | — | EP | claimed |
| WO-2018134710-A1 | ENZYMATIC REACTION MEDIUM CONTAINING SURFACTANT | NOVARTIS AG (CH) | 2018-07-26 | — | — | WO | claimed |
| WO-2018060843-A1 | SURFACTANT SYSTEMS FOR CRYSTALLIZATION OF ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2018-04-05 | — | — | WO | claimed |
| WO-2018011696-A1 | CATALYSTS FOR CHEMICAL REACTIONS IN A WATER-SURFACTANT MIXTURE | NOVARTIS AG (CH) | 2018-01-18 | — | — | WO | claimed |
| WO-2017168303-A1 | REACTION MEDIUM CONTAINING WATER-SURFACTANT MIXTURE | NOVARTIS AG (CH) | 2017-10-05 | — | — | WO | claimed |
| US-20250332263-A1 | SURFACTANT STABILIZERS | NOVARTIS AG (CH) | 2025-10-30 | — | — | US | disclosed |
| EP-4412583-A1 | SURFACTANT STABILIZERS | Novartis AG (CH) | 2024-08-14 | — | — | EP | disclosed |
| US-12024508-B2 | Dihydroquinazolinones exhibiting protective activity against intracellular-acting toxins, intracellular viruses and bacteria | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2024-07-02 | — | — | US | disclosed |
| US-20080031848-A1 | Preparation of Polymer Conjugates of Therapeutic, Agricultural, and Food Additive Compounds | ELAN PHARMACEUTICALS, INC. | 2008-02-07 | — | — | US | disclosed |
| US-20080006798-A1 | Photochromic Compositions and Light Transmissible Articles | JAMES ROBINSON SPECIALITY INGREDIENTS LTD (GB) | 2008-01-10 | — | — | US | disclosed |
| US-7247262-B2 | Photochromic compositions and light transmissible articles | POLYMERS AUSTRALIA PTY LTD. (AU) | 2007-07-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250332263-A1 | SURFACTANT STABILIZERS | SMURF1, SMURF2, ALB | ALDH1A1 4753/4885ADRA2A 2987/4885ADRA1A 2791/4885 |
| US-20080031848-A1 | Preparation of Polymer Conjugates of Therapeutic, Agricultural, and Food Additive Compounds | PIGO, MANBA, OAT | ALDH1A1 174/4885ADRA2A 4336/4885ADRA1A 3742/4885 |
| US-12024508-B2 | Dihydroquinazolinones exhibiting protective activity against intracellular-acting toxins, intracellular viruses and bacteria | STX18, STXBP1, NSF | ALDH1A1 4618/4885ADRA2A 2005/4885ADRA1A 2101/4885 |
| US-20220274966-A1 | SURFACTANT SYSTEMS FOR CRYSTALLIZATION OF ORGANIC COMPOUNDS | OSTC, SPOP, LSS | ALDH1A1 4377/4885ADRA2A 3840/4885ADRA1A 3608/4885 |
| US-20200299281-A1 | REACTION MEDIUM CONTAINING WATER-SURFACTANT MIXTURE | SRR, PHOSPHO1, NAPEPLD | ALDH1A1 4350/4885ADRA2A 3719/4885ADRA1A 3681/4885 |
| US-11236076-B2 | Reaction medium containing water-surfactant mixture | SRR, PHOSPHO1, NAPEPLD | ALDH1A1 4350/4885ADRA2A 3719/4885ADRA1A 3681/4885 |
| US-20190308180-A1 | CATALYSTS FOR CHEMICAL REACTIONS IN A WATER-SURFACTANT MIXTURE | LSS, DCXR, CEL | ALDH1A1 4088/4885ADRA2A 4372/4885ADRA1A 4437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.